Shares of bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as $128.25 and last traded at $128.25, with a volume of 57 shares trading hands. The stock had previously closed at $123.64.
bioMérieux Price Performance
The company has a current ratio of 2.21, a quick ratio of 1.20 and a debt-to-equity ratio of 0.10. The company’s fifty day moving average is $122.66 and its 200-day moving average is $114.31.
About bioMérieux
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Read More
- Five stocks we like better than bioMérieux
- How to Invest in Small Cap Stocks
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Stock Dividend Cuts Happen Are You Ready?
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Following Congress Stock Trades
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
